Interleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor α gene to transcription factors

被引:0
|
作者
Rusterholz, C [1 ]
Henrioud, PC [1 ]
Nabholz, M [1 ]
机构
[1] Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-2 (IL-2) responsiveness of T lymphocytes is controlled through transcription of the IL-2 receptor (IL-2R) alpha subunit by antigen and by IL-2 itself. IL-2 induces IL-2R alpha transcription via an IL-2-responsive enhancer (IL-2rE), whose activity depends on the cooperative binding of IL-2-induced STAT5 to two sites and of constitutively active Elf-1 to a third one. Here we describe the changes in IL-2rE chromatin that occur in normal T lymphocytes upon activation of IL-2R alpha expression. In cells induced to transiently express IL-2R alpha with concanavalin A (which mimics antigen), none of the IL-2rE sites is occupied despite the presence of Elf-1 and STAT1, which bind to the IL-2rE in vitro. The two STAT binding sites are occupied rapidly upon IL-2 stimulation, concomitantly with STAT5 activation. Occupation of the Elf-1 binding site is delayed, although Elf-1 concentration and binding activity are not modified by IL-2. Digestion of T-cell chromatin with DNase I and micrococcal nuclease shows that IL-2 induces the appearance of nuclease-hypersensitive sites flanking the IL-2rE. Thus IL-2, in addition to activating STAT5, appears to regulate IL-2R alpha transcription by making IL-2R alpha chromatin accessible to transcription factors.
引用
收藏
页码:2681 / 2689
页数:9
相关论文
共 50 条
  • [21] ROLE OF INTERLEUKIN-2 (IL-2) IN CANCER-RELATED IMMUNE-DEFICIENCY - INVITRO RESPONSE TO IL-2, PRODUCTION OF IL-2, AND IL-2 RECEPTOR EXPRESSION IN PATIENTS WITH ADVANCED CANCER
    MANTOVANI, G
    COIANA, A
    MASSIDDA, A
    PROTO, E
    FLORIS, C
    MACCIO, A
    PUSCEDDU, G
    DELGIACCO, GS
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 149 - 159
  • [22] Lipoteichoic acid inhibits interleukin-2 (IL-2) function by direct binding to IL-2
    Plitnick, LM
    Jordan, RA
    Banas, JA
    Jelley-Gibbs, DM
    Walsh, MC
    Preissler, MT
    Gosselin, EJ
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (05) : 972 - 979
  • [23] PHOSPHORYLATION OF HUMAN INTERLEUKIN-2 (IL-2)
    KUNG, HF
    CALVERT, I
    BEKESI, E
    KHAN, FR
    HUANG, KP
    OROSZLAN, S
    HENDERSON, LE
    COPELAND, TD
    SOWDER, RC
    WEI, SJ
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1989, 89 (01) : 29 - 35
  • [24] CLONING OF THE BOVINE INTERLEUKIN-2 (IL-2) RECEPTOR CDNA
    WEINBERG, A
    ELLIOTT, J
    PAETKAU, V
    BLEACKLEY, C
    MAGNUSON, N
    REEVES, R
    MAGNUSON, J
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 770 - 770
  • [25] INHIBITION OF INTERLEUKIN-2 (IL-2) PRODUCTION AND IL-2 RECEPTOR EXPRESSION BY PROTEIN-KINASE-C INHIBITOR
    VAYUVEGULA, B
    SHIMIZU, M
    GUPTA, S
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 461 - 461
  • [26] SEVERE COMBINED IMMUNODEFICIENCY, INTERLEUKIN-2 (IL-2), AND THE IL-2 RECEPTOR - EXPERIMENTS OF NATURE CONTINUE TO POINT THE WAY
    VOSS, SD
    HONG, R
    SONDEL, PM
    BLOOD, 1994, 83 (03) : 626 - 635
  • [27] INTERLEUKIN-2 (IL-2) AND IL-2 RECEPTOR DETERMINATION ON BLOOD-LYMPHOCYTES AND SYNOVIAL-FLUID LYMPHOCYTES
    LEMM, G
    WARNATZ, H
    IMMUNOBIOLOGY, 1985, 170 (1-2) : 54 - 55
  • [28] BIOTINYLATION OF INTERLEUKIN-2 (IL-2) FOR FLOW CYTOMETRIC ANALYSIS OF IL-2 RECEPTOR EXPRESSION - COMPARISON OF DIFFERENT METHODS
    DEJONG, MO
    ROZEMULLER, H
    BAUMAN, JGJ
    VISSER, JWM
    JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 184 (01) : 101 - 112
  • [29] EFFECTS OF HYPERLIPEMIC SERUM ON INTERLEUKIN-2 (IL-2) PRODUCTION, IL-2 RECEPTOR EXPRESSION, AND T-CELL PROLIFERATION INDUCED BY IL-2 IN CYNOMOLGUS MONKEYS
    TERAO, K
    FUKASE, Y
    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1991, 44 (01): : 17 - 28
  • [30] SERUM SUPPRESSION OF INTERLEUKIN-2 (IL-2) PRODUCTION AND IL-2 ACTION IN THERMAL-INJURY
    RODRICK, ML
    SAPOROSCHETZ, IB
    WOOD, JJ
    DAVIS, CF
    MANNICK, JA
    SURGICAL FORUM, 1985, 36 : 98 - 99